neuroscience

NVS

Pharma

Novartis charts another 60 layoffs at US corporate outpost

Novartis added a handful of additional roles from its U.S. headquarters to the company's multiyear workforce reductions.

Fraiser Kansteiner May 4, 2026 11:09am

Lundbeck

After Avadel setback, Lundbeck signals future M&A rigor

Jan 22, 2026 11:13am

AbbVie will continue to pursue external innovation for long-term

Jul 31, 2025 11:44am

BMS

BMS' schizophrenia drug stumbles in blow to blockbuster plan

Apr 23, 2025 10:35am

Alkermes

Even through its remake, Alkermes retains upward trajectory: CEO

Jan 13, 2025 7:36am

Top Line

A revival in neuro therapeutics

Oct 11, 2024 8:37am